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ABSTRACT
Purpose: To develop a reliable surgical model of acute hepatic failure and hyperammonemia in rats that avoids porto-systemic shunt and
bile duct ligation, applicable to hepatic encephalopathy research. Methods: The pedicles of right lateral and caudate lobes were exposed
and clamped. One hour later, the animal was reopened, clamps were released and anterior subtotal hepatectomy (resection of median and
left lateral lobes) was performed, comprising 75% of liver removal. Four hours after hepatectomy, blood samples and liver tissues were
collected from ALF and control groups. Results: Differences between ALF and control groups were significant for ALT, AST, total and
direct bilirubin, sodium, potassium, alkaline phosphatasis, gamma-glutamyltransferase and most important, ammonia. Histologically,
significant differences were noticed between groups. Conclusion: The model is useful for the study of specific aspects of ALF and the
development of new therapeutic approaches.
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RESUMO
Objetivo: Desenvolver um modelo cirúrgico de IHA e hiperamonemia em ratos, que evita o shunt porto-sistêmico e a ligadura do
ducto biliar, que seja aplicável à pesquisa de encefalopatia hepática. Métodos: Após anestesia geral e laparotomia mediana, os
pedículos dos lobos laterais direito e caudado foram isolados e clampeados. Após 1 hora, o animal foi reaberto, os clampes retirados
e foi realizada hepatectomia anterior subtotal (ressecção dos lobos médio e lateral esquerdo), compreendendo a remoção de 75% do
parênquima. Quatro horas após a hepatectomia, amostras de sangue e tecido hepático foram coletadas nos grupos IHA e controle.
Resultados: Diferenças entre os grupos IHA e controle foram significativas para ALT, AST, bilirrubina total e direta, sódio, potássio,
fosfatase alcalina, gama glutamiltransferase e principalmente amônia. Histologicamente, diferenças significativas foram observadas
entre os grupos. Conclusão: O modelo é útil para o estudo de aspectos específicos da IHA e o desenvolvimento de novas abordagens
terapêuticas.
Descritores: Falência Hepática Aguda. Encefalopatias. Rats.
1Research performed at Transplantation Division, Laboratory of Medical Investigation, Department of Gastroenterology, School of Medicine,
University of São Paulo (USP), Brazil.
Introduction
Acute liver failure (ALF) is a morbid condition that
may result in severe neurological complications such as hepatic
encephalopathy and brain edema leading to intracranial
hypertension, brain herniation, and death. Despite several
advances in the clinical management of patients with acute
liver failure (ALF), this condition remains extremely serious and
results in high mortality rates. Viral hepatitis and drug-induced
hepatotoxicity (in particular acetaminophen overdose) are the
most frequent causes of ALF, although their relative incidence
varies markedly in different parts of the world1. The difficulties
inherent to the management of patients with ALF can be explained
in part by the serious systemic and neurological complications of
ALF, which include hypoglycemia, renal failure, coagulopathy,
sepsis, multiorgan failure, intracranial hypertension, and hepatic
encephalopathy2. Liver transplantation remains the only effective
treatment of ALF, but its availability is often limited by the chronic
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shortage of donor livers. Since a large number of patients will not
have access to orthotopic liver transplantation, they will die while
waiting for an organ. That emphasizes the need in developing new
strategies for the management and treatment of ALF.
Despite several years of research, the complete
comprehension of the pathogenesis of brain edema and hepatic
encephalopathy in ALF remains incomplete. Mechanisms
involving ammonia have also been proposed in the pathogenesis
of cellular swelling and ultimately brain edema in acute liver failure.
In an experimental model of acute liver failure, development of
brain edema and declining neurological status were correlated with
increasing arterial ammonia concentrations3.
The development of appropriate animal models of ALF
is paramount for the understanding of the pathogenesis of ALF,
the progression and management of the complications of ALF,
and the mechanisms involved in liver regeneration. In addition,
animal models are needed for the development and trial of new
therapeutic approaches in ALF.
The most common approaches used to induce experimental
ALF include surgical strategies, hepatotoxic drugs, and viral models.
Among surgical approaches in rats, many strategies have been
developed: total hepatectomy4, partial hepatectomy5, complete
hepatic devascularization (a portacaval anastomosis followed by
ligation of the hepatic artery)6, and combined surgical/hepatotoxic
models7.
The development of an ideal model of ALF has been
remarkably difficult to achieve. The reproducibility of surgical
models relies extensively on the availability of appropriate
surgical expertise; however, one of their advantages is that
they specifically affect the liver thus eliminating the problem of
extrahepatic toxicity8.
A good model of ALF in rats is yet needed for further
research concerning encephalopathy. The aim of this study was to
develop a reliable surgical model of ALF and hyperammonemia in
rats without the necessity of microsurgery skills, which avoids
portosystemic shunt and bile duct ligation, applicable to hepatic
encephalopathy research.
Methods
The study was designed in accordance with the Guide
for the Care and Use of Laboratory Animals published by the
US National Institutes of Health and the Guidelines of Animal
Experimentation of the University of São Paulo School of
Medicine, São Paulo, SP, Brazil, for the care and use of laboratory
animals. The experimental protocol was pre-approved by Ethics
Commission of the Hospital das Clínicas, University of São Paulo,
Brazil.
Fourteen male Wistar rats weighing 250 ± 5 g were housed
in cages with a controlled 12-h light/dark cycle, receiving water ad
libitum. Before the day of experiment animals fasted overnight but
free access to water was allowed. Animals were anestethized with
ketamin 5% (30 mg/kg) and xylazine 2% (30 mg/kg)
intraperitonially. During the experiment animals were warmed
by halogen light (45W, 127V) and corporeal temperature was
controlled by digital thermometer (YSI Precision 4000A
thermometer, USA) and kept around 37°C. Animals were
maintained in spontaneous ventilation with an oxygen-enriched
mixture (40%) during all the procedure.
Experimental design
A median laparotomy was performed and the pedicles of
right lateral and caudate lobes were clamped with an atraumatic
microvascular bulldog clamp (Figure 1). In this technique, pedicle
clamping is completely reversible, avoiding intestinal and caval
stasis. After clamping, the abdominal wall was closed with
uninterrupted 4-0 nylon suture in order to avoid dehydration.
One hour later, the animal was reopened, clamps were released
and 75% liver resection was performed for the removal of the
median and left lateral lobes. Following this partial hepatectomy,
the remaining liver consisted of the right lateral lobe, caudate
lobe, and pericaval parenchyma (Figure 2). The abdominal wound
was then closed. Blood samples and liver tissues were collected
from ALF and CTRL groups, four hours after hepatectomy. At
this time, all animals were space-disoriented and dizzy, probably
due to hyperammonemia.
FIGURE 1 - Experimental design of rat partial hepatic
ischemia. The pedicles of right lateral and caudate lobes
were clamped to promote a sublethal ischemia of the liver.
The blood flow remains stable into the median and left
lateral lobes. 1. Infrahepatic vena cava. 2. Portal vein.
3. Suprahepatic vena cava
Acta Cirúrgica Brasileira - Vol. 25 (3) 2010  -  271
A new experimental model for acute hepatic failure in rats
Blood sampling and analyses
Albumin, hepatic enzymes [alanine aminotransferase
(ALT), aspartate aminotransferase (AST), alkaline phosphatasis
(AP) and gamma-glutamyltransferase], total and direct bilirubin,
urea and creatinine levels were quantified using a clinical chemistry
kit on Cobas Mira analyzer, according to the manufacturer’s
instructions.
Special attention was paid to specimen handling for
analysis of ammonia levels. All samples were placed on ice
immediately after collection and processed within 20 minutes.
Serum ammonia levels were determined with a Cobas Integra 400
Analyzer. Sodium and potassium levels were determined with a
Modular P Analyzer.
Histological analysis
Fragments of liver tissue previously fixed in 10%
formalin solution were processed and stained with hematoxylin-
eosin.
Statistical analysis
Comparisons between groups were statistically analyzed
using GraphPad Prism 2.01 software. An unpaired t-test was
performed. Mean values and SEM were displayed in graphics only
as additional information. Differences were considered statistically
significant when p < 0.05.
Results
Alanine aminotransferase, aspartate aminotransferase, total
and direct bilirubin, sodium, potassium, alkaline phosphatasis,
gamma-glutamyltransferase and ammonia were assessed four hours
after hepatectomy. Differences between ALF and CTRL groups
were significant (Figures 3, 4 and 5).
FIGURE 2 - Partial hepatectomy. After the resection of median and left lateral lobes, previously ischemic right
lateral and caudate lobes remain. 1. Infrahepatic vena cava. 2. Portal vein. 3. Suprahepatic vena cava
FIGURE 3 - Serum levels of alanine aminotransferase (ALT)
(ALF group: 2526±498.5, CTRL group: 81.67±7.032), aspartate
aminotransferase (AST) (ALF group: 3134±512.8, CTRL group:
128.3±7.032), total (ALF group: 1.980±0.476, CTRL group:
0.400±0.063) and direct (ALF group: 1.180±0.257, CTRL group:
0.300±0.063) bilirubin, four hours after hepatectomy
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There were no statistical differences between ALF and
CTRL groups concerning albumin, creatinine and urea (Figure 6).
FIGURE 6 - Serum levels of albumin (ALF group: 3.020±0.080, CTRL group: 2.967±0.0615), creatinine (ALF group:
0.800±0.247, CTRL group: 0.383±0.017) and urea (ALF group: 39.6±4.057, CTRL group: 34.33±3.480), four hours after
hepatectomy
FIGURE 4 - Serum levels of sodium (ALF group: 138.8±1.315,
CTRL group: 146.0±1.183), potassium (ALF group: 9.975±1.039,
CTRL group: 6.150±0.457), alkaline phosphatasis (ALF group:
959.8±89.68, CTRL group: 590.7±27.44) and gamma-
glutamyltransferase (ALF group: 16.20±6.606, CTRL group:
2500±0.342) four hours after hepatectomy
FIGURE 5 - Serum levels of ammonia (ALF
group: 450.0±161.9, CTRL group:
77.0±25.53), four hours after hepatectomy
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Discussion
Extensive resection of the liver results in ALF and mortality
due to insufficient liver function of the remnant parenchyma. Under
a certain threshold, however, partial hepatectomy is followed by
intense liver regeneration and complete recovery5.
After a major hepatectomy, a small amount of remnant
liver carries the duty of providing all energetic and metabolic
necessities in the post-operative period. When the remaining
liver is not sufficient, encephalopathy and coma take place and
death is inevitable. This is a tragic situation that occurs sometimes
in clinical situation. This also may occur in the set of living related
liver transplantation, when the graft is small-for-size. Those two
situations are catastrophic and must be avoided at most.
The comprehension of the mechanisms involved in the
brain damage caused by hyperammonemia and ALF is vital. Thus,
there is still a need for an experimental model that represents to the
best the clinical situation9.
In general, models of partial hepatectomy do not result
in hepatic coma and do not mimetize the clinical picture seen
in patients with ALF. These models, however, are well suited for
the study of liver regeneration10.
In rats, it has been demonstrated that the high mortality
observed following resection of 90% of liver mass5 can be greatly
attenuated by the simple prevention of hypoglycemia11. Roger
et al.11 proposed a model of 95% hepatectomy resulting in 80%
mortality even with the control of hypoglycemia. Unfortunately,
very little is known about the biochemical changes and the
neurological symptoms occurring in this model11. Complete
hepatic devascularization models (portocaval shunt and hepatic
artery ligation, with or without bile duct ligation) are irreversible
and result in death within a relatively short period of time. Animals
show progressive encephalopathy and hepatic coma similar to
those observed in patients with ALF. In addition, this model is
accompanied by brain edema and raised intracranial pressure, which
makes it useful for the study of these neurological complications
of ALF12. In large animals, such models have been widely used to
investigate the therapeutic potential of bioartificial and artificial
liver support systems13. Nevertheless those models require advanced
microsurgical skills and a high mortality rate is expected when
performed in rats.
Studies in animal models of acute and chronic liver
failure reveal significant increases in seric ammonemia and brain
ammonia uptake. This effect is due to increased permeability of
the blood–brain barrier in liver failure as well as to other factors
such as alterations of cerebral blood flow14.
Our study mimetizes quite well human acute liver failure.
Results of the present study reveal significant alterations in hepatic
enzymes, sodium, potassium, total/direct bilirubin and
hyperammonemia resulting from hepatic devascularization followed
75% liver resection. The precise mechanisms responsible for the
induction of encephalopathy in liver failure are not completely
understood. However, a number of studies suggest that
hyperammonemia, which is a common feature of chronic and acute
liver failure, is implicated. There is substantial evidence to suggest
that hyperammonemia is one of the main factors contributing to
the neurological alterations found in hepatic encephalopathy15. An
understanding of the various mechanisms by which
hyperammonemia exerts its effects, may provide a valuable approach
to further elucidate the pathogenesis of hepatic encephalopathy
and brain edema occurring as a result of acute liver failure.
In the present study, we developed a simple, not expensive,
reproducible model of ALF and clinical encephalopathy in rats,
using transient and restricted ischemia followed by a partial
hepatectomy. This model does not need specific skills in
microsurgery like others and it is similar to human clinical
condition. The model is useful for the study of specific aspects of
ALF and the development of new therapeutic approaches. An
understanding of the various mechanisms by which
hyperammonemia exerts its effects, may provide a valuable approach
to further elucidate the pathogenesis of hepatic encephalopathy and
brain edema occurring as a result of acute liver failure.
Histological liver assessment showed a menagerie of
alterations in ALF group (Figure 7).
FIGURE 7 - Normal liver histology in CTRL group (A); Abnormal liver histology in ALF group (B) showing
the presence of degenerative alterations: detrabeculation, microvesicular steatosis as well as diffuse and intense
sinusoidal congestion (100X)
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Conclusion
The model is useful for the study of specific aspects of
ALF and the development of new therapeutic approaches.
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